complex. 1 FXa forms the prothrombinase complex with FVa and mediates the conversion of prothrombin to thrombin. FXa, its cofactor FVa, and thrombin form the common pathway leading to thrombinmediated cleavage of fibrinogen to fibrin which is then cross-linked by activated FXIII forming a stable clot. 8 Nowadays, a clear separation of the extrinsic and the intrinsic pathways is difficult since it was shown that the TF:FVIIa complex can also lead to activation of the intrinsic coagulation protease FIX and thrombin can activate FXI. 9 FXII does not play a role hemostasis but can contribute to thrombosis as well as inflammatory responses. 10 Importantly, there is an ongoing effort to develop new anticoagulants targeting the intrinsic pathway, since deficiencies or inhibition of FXIand FXII-reduced thrombosis in experimental and clinical studies without a major impact on hemostasis, e.g, spontaneous bleedings.
10,11
| Coagulation-dependent signaling
Besides leading to a stable clot, active proteases generated during the coagulation cascade can directly induce cell-specific signaling via the cleavage of protease-activated receptors (PARs). 12 PARs form a receptor family with four members, PAR1-4. 13 Briefly, the TF:FVIIa complex and FXa can activate PAR2. 14 Thrombin is the primary activator of PAR1, PAR3, and PAR4. Further, FXa can activate PAR1. PARs are ubiquitously expressed within the body in similar patterns across mammals. 13, 14 However, there is a significant difference between human and rodent PAR expression on platelets. Human platelets express PAR1 and PAR4 whereas murine platelets express PAR3 and PAR4. 14 Several studies showed that PARs modulate innate immune responses by crosstalk with toll-like receptors (TLRs). [15] [16] [17] [18] [19] Antibacterial TLR4 signaling is enhanced by PAR2, whereas PAR2 reduces antiviral responses via TLR3. 15, 16, 19 This PAR2-dependent TLR modulation is thought to be through direct receptor:receptor interaction. 16, 19 In addition, we have shown that coagulation-dependent PAR1 signaling enhances TLR3-dependent antiviral responses. 17, 18 Unfortunately, experimental studies with global PAR-deficient mice were not able to reveal any major contribution of PARs to the pathologies of bacterial infection or endotoxemia. 20 In contrast to bacterial infections, there are clear phenotypes in PAR1-and PAR2-deficient mice in different viral infection models. [14] [15] [16] [17] [18] It could be speculated that host proteases, such as thrombin, stimulate the antiviral response via PAR1, whereas viral proteases may activate PAR2 in an attempt to dampen the antiviral response of the host and increase virus infectivity. 17 Newer mouse models with different cleavage-insensitive PAR1
and PAR2 mutant knock-in mice might uncover a biased proteasedependent signaling to certain infections which were hidden in global PAR1 or PAR2 knock-out mice.
21,22
| Infections and the activation of coagulation
The coagulation system is activated in response to infection by a variety of different pathogens, including bacteria and viruses (Tables 1   and 2) . 14, 18, 20, 23, 24 This response appears to have developed as a host defense system to limit the spread of the pathogen. During infections, there is an interplay between blood coagulation, immune cells, and platelets to restrict dissemination of pathogens within the body. Fibrin(ogen) has a central role in hemostasis and thrombosis but it also contributes to multiple physiologic and pathologic processes beyond blood coagulation. 29, 30 Reduced fibrin(ogen) levels are a predictor for hemorrhagic complications. 31 In addition, fibrin clots were shown to be a strong inducer of a proinflammatory response of in clot-embedded monocytes and timely degradation via fibrinolysis can dampen this inflammatory response. The reported inflammatory response was thrombin-independent but fibrin-dependent. 32 Innate immune cells responding via the integrin receptor α M β 2 (CD11b/ CD18, Mac-1) to the γ chain of fibrin(ogen) by phagocytosis, generation of reactive oxygen species and NFκB-mediated gene expression of proinflammatory mediators. 33 Interestingly, a report showed that soluble fibrin(ogen) can bind and induce signaling in neutrophils independently of Mac-1 in vitro which suggests an additional fibrin(ogen) receptor. 34 Mac-1 was further identified as a surface receptor for dsRNA on macrophages mediating TLR3-dependent and -independent immune responses. 35 The dsRNA:Mac-1 interaction was blocked by treatment of cells with fibrin(ogen • FXII/FXIIa has no effect on murine and human neutrophil phagocytosis • FXII does not contribute to coagulation activation in Klebsiella and Streptococcus pneumoniae • FXI deficiency results in higher mortality during Klebsiella and Streptococcus pneumonia associated with higher bacterial out growth and inflammatory response • FXI does not contribute to coagulation activation in Klebsiella and Streptococcus pneumonia • FXIa is needed for phagocytosis of bacteria by murine and human neutrophils • FXI might be activated by thrombin generated via the extrinsic pathway • Thrombin inhibition by dabigatran etexilate increased Klebsiella infection but has no effect on activation of coagulation, thrombocytopenia and fibrin deposition • Thrombin mediated platelet:neutrophil interaction is needed to limit Klebsiella growth • Fibrin degradation/clot lysis due to bacterial proteases leads to increased bleeding tendencies in cystic fibrotic lungs [79] [80] [81] shown to enhance intrinsic pathway activation in vitro. 51 However, FXII can also be activated by an alternative mechanism via proteases, including elastase and plasmin. 50 Certain bacteria were shown to express specific LPS, polyphosphates, elastase, or plasminogen activators to trigger bradykinin production via FXII activation. 50, 52, 53 The alternative activation mechanism of FXII results in a significant reduced activation of coagulation and shifting FXIIa towards its proinflammatory role. 50 The remainder of this review will focus on the role of the coagulation cascade in infections with selected pathogens with particular attention paid to the intersection of the hemostatic system with antibacterial and antiviral immune responses (Tables 1 and 2 ).
| Bacterial pneumonia
Pneumonia studies with the Gram-negative Klebsiella pneumoniae or the Gram-positive Streptococcus pneumoniae are widely used to investigate local pathogen-host interactions (Table 1) . Both bacteria were shown to lead to local activation of coagulation and fibrin deposition in the lungs. 54, 55 Interestingly, while systemic inhibition of TF was beneficial in sepsis and endotoxemia, a global deficiency of TF (LowTF mice) during LPS administration into the lung led to increased pulmonary hemorrhages and lung inflammation. 20, 56 Tissue hemostasis and lung-dependent activation of coagulation during local endotoxemia is mediated by TF expressed on lung epithelial cells and not myeloid cells. 57 However, TF deficiency on both cell types did not significantly affect local lung inflammation. 57 In line with this, myeloid TF had no effect on Klebsiella pneumonia-induced lung injury. 58 Notably, a lack of myeloid TF increased the expression of KC/CXCL1, a neutrophil chemoattractant and the murine homolog to human IL-8, in the lung after Klebsiella infection and local LPS administration. 57, 58 This suggests that myeloid TF is a negative regulator for macrophage infiltration into the alveolus during bacterial infection. 57 Moreover, Kral-Pointner et al reported in acid-induced lung injury a myeloid TF-dependent anti-inflammatory effect within the lung. Mice lacking myeloid cell TF exhibited increased neutrophil accumulation in the lung. Furthermore, in vitro studies showed that myeloid TF dampened NFκB-dependent responses after hydrochloric acid stimulation. 59 Interestingly, in infection, myeloid TF was needed to control bacterial growth. 60 A lack of myeloid cell TF resulted in less fibrin deposition and a M2 macrophage phenotype within the lung. 60 However, when using a global TF deficient mouse (LowTF mice) this difference was not detectable which could be due a low but still sufficient TF expression in macrophages. 61 Further, Rauch's group found that the FXa inhibitor fondaparinux increased a M2 macrophage phenotype in the mouse heart during viral myocarditis. 62 • Thrombin-PAR1 signaling increases T Cell motility and cytokine expression 17, [87] [88] [89] [90] [91] [92] [93] It was shown that thrombin activity leads to endothelial cell activation in Klebsiella infection. 54 Interestingly, thrombin inhibition and fibrin depletion resulted in increased Klebsiella infection in mice associated with increased bacterial outgrowth and dissemination leading to higher mortality. 54 However, the thrombin inhibitor dabigatran had no effect on neutrophil recruitment, activation, and NET formation, but it dampened coagulation activation measured by reduced D-dimer and thrombin-antithrombin (TAT) levels, and fibrin depositions within the lung. 54 Whole blood assays showed that the combination of active thrombin, platelets, and neutrophils were essential to limit Klebsiella growth. 54 Interestingly, the authors observed that thrombin-mediated PAR1 activation on platelets reduced Klebsiella growth in human blood by enhancing plateletneutrophil interaction. 54 Further, thrombin inhibition reduced platelet-neutrophil interaction in Klebsiella pneumonia but did not effected thrombocytopenia. 54 These findings suggested that extrinsic pathway generated thrombin mediates fibrin polymerization and platelet-neutrophil interactions are essential for protective immune responses in at least
Klebsiella pneumonia-derived sepsis. 54 Furthermore, FXI is activated by extrinsic pathway generated thrombin independently of FXIIa in bacterial pneumonia which influences the antibacterial function of neutrophils. 55 Importantly, bacteria can support the activation of plasminogen on their surface. 63 Increased clot lysis and fibrin degradation would lead to bacterial dissemination. Cystic fibrosis is associated with specific bacterial colonization of the lung and can cause hemoptysis a hallmark of "cepacia syndrome". 64 Within the cystic fibrosis lung, bacterial proteases as well as neutrophil elastase are generated/ released which were shown to degrade fibrin. 64 Cystic fibrosis hemoptysis is therefore a result of infection-driven immune responses causing a failure of lung integrity and affecting lung hemostasis, which subsequently leads to hemorrhages into the airway lumen during the phase of acute infection.
64-66
| Bacterial peritonitis
To analyze the effect of systemic bacteremia/sepsis and endoxemia, mice are subjected to intraperitoneal or intravenous injection of bacteria or endotoxin as well as cecal ligation and puncture (CLP)
surgery. The majority of the studies that have analyzed the role of the coagulation system in peritonitis and sepsis use Staphylococcus aureus, Yersinia pestis and Escherichia coli ( Table 1 ). The interaction between the host's coagulation/immune system and S. aureus were extensively reviewed recently in detail. 67 It was repeatedly shown that the TF pathway is essential for the induction of coagulation in endotoxemia and sepsis, which subsequently leads to tissue injury and mortality. 20, 44, 68, 69 Further, inhibition of TF-dependent activation was reported to improve survival in endotoxemia and sepsis. 20 The major contributor in endotoxemia induced systemic coagulation activation is TF expressed by myeloid cells as well as by cells of unknown perivascular origin. 44 Interestingly, Bastarache's group was not able to show that myeloid TF had any role in indirect lung injury during endotoxemia and CLP sepsis. 58 In addition, the prothrombotic phenotype of FV Leiden heterozygosity in mice poses a survival ad- Studies showed an important role for fibrin(ogen) and FXIII to limit bacterial dissemination (Table 1) . 26, 29, 75, 76 To analyze the role of fibrin in bacterial infections, Prasad and colleagues generated mice carrying a thrombin-cleavage resistant fibrinogen Aα chain (Fib AEK ).
While these mice have normal levels of circulating fibrinogen levels and support normal platelet:fibrinogen interaction they are unable to produce fibrin polymers. 77 Interestingly, Fib AEK mice exhibited a profound impediment in S. aureus clearance following intraperitoneal infection similar to Fib −/− mice but had a significant infection dose-dependent survival advantage over Fib −/− mice following peritonitis challenge. 77 This indicates that the fibrin polymerization is critical for the antibacterial action while circulating fibrinogen has additional protective functions possible due to platelet interaction.
In addition, mice lacking the last five amino acids of the fibrinogen γ chain (Fibγ Δ5 ) exhibited improved survival after S. aureus infection compared to WT and Fibγ 390-396A . 78 Platelet and platelet integrin receptor subunit α IIb deficient mice established that the survival benefits observed in Fibγ Δ5 mice were largely independent of platelet α IIb β 3 -mediated engagement of fibrinogen.
| Bacterial skin infection
Skin infection with Streptococcus pyogenes (Group A streptococcus) is a major public health concern. While local infection is mostly uncomplicated, a systemic dissemination is associated with streptococcal toxic shock syndrome. Ginsburg's group reported that FV and fibrinogen deficiency in mice resulted in increased S. pyogenes infection, suggesting that FV-dependent fibrin deposition was needed to reduce pathogen dissemination (Table 1) . 79 However, FV Leiden had no effect on S. pyogenes infection. 79 In line to the findings with fibrinogen deficiency, FXIII deficiency during S. pyogenes infection evokes a pathologic inflammatory reaction causing massive neutrophil influx at the side of infection. 80 In addition, FXIII is essential for immobilization of bacteria, such as S. pyogenes, within the fibrin network which prevents bacterial dissemination and reduced inflammatory overreaction. 81 Furthermore, local FXIII application at the site of infection resulted in a reduction bacterial dissemination indicating that FXIII mediates protection during early S. pyogenes skin infection by supporting early innate immune response. 81 There are compelling data that reducing coagulation activation can improve the outcome in endotoxemia (Table 1) 
| Viral pneumonia
Recently, we showed that TF is induced in the lung after H1N1 IAV infection in mice which led to increased activation of coagulation via increased TF activity in the lung and by TF+MV in the bronchoalveolar lavage fluid (BALF) ( Table 2) . 23 The induction of TF and activation of coagulation was abolished in mice with a global TF deficiency (LowTF mice) and mice with a TF deletion in lung epithelial cells suggesting that lung epithelial cells are the main source for inducible TF in the lung and driver of coagulation after H1N1 IAV infection. 23 Furthermore, LowTF mice and mice lacking lung epithelial cell TF presented with increased alveolar hemorrhages and death in sub-lethal H1N1 IAV infection. 23 Importantly, we could not find any contribution for myeloid, endothelial, or hematopoietic TF on the activation of coagulation nor survival after H1N1 IAV infection. 23 The current studies indicating that H1N1 IAV infection is a hemostatic challenge and epithelial cell TF-dependent fibrin deposition mediates lung hemostasis. 23, 39 Indeed, reduction of fibrin(ogen) levels with the snake venom ancrod led to an increase of H1N1 IAV infection pathology in mice. 82 However, during severe H1N1 IAV infection, increased TF levels, possible on macrophages, can be deleterious due to increased TF activity on MV in plasma which was associated with increased mortality in H1N1 IAV infected patients. 83 We found that dabigatran decreased activation of coagulation in the lung measured by TAT levels in the BALF of H1N1 IAV infected mice which was associated with increased pulmonary hemorrhages. 39 However, we could not find any differences in the survival between dabigatran and placebo treated H1N1 IAV infected mice. 39 Importantly, we observed that anticoagulation with the vitamin-K antagonist warfarin increased pulmonary hemorrhages and mortality of H1N1 IAV infected mice. 39 Anticoagulation with warfarin unselective reduces the vitamin K-dependent procoagulant factors prothrombin, FVII, FIX, FX, and the anticoagulant factors protein C and S, whereas dabigatran only inhibits thrombin activity. APC and FVII were shown to facilitate vascular protection via the endothelial protein C receptor and PAR1 in certain disease models. We found that warfarin but not dabigatran significantly increased vascular permeability in the lung after H1N1 IAV infection compared to H1N1 IAV alone. 39 In support of our findings, APC administration reduced Dengue virus mediated endothelial permeability and inflammatory response, 84 which suggests that APC may be protective during Dengue virus and possible other viral infections. However, the action of APC might be more complicated since inhibition of APC was shown to worsen lung histopathology but lowered neutrophil influx and delayed mortality during lethal IAV infection in mice. 85 We found that PAR1 −/− mice exhibited increased inflammation in the lung early after H1N1 IAV infection. 18 However, thrombin inhibition had no effect on inflammation and survival after H1N1 IAV infection suggesting that thrombin might not be the major PAR1 activator in this model. 39 As mentioned before, cleavage-resistant PAR1 knock-in mice might reveal the relative contribution of thrombin-vs APCdependent PAR1 activation in H1N1 IAV infections. 21 With regard to the intrinsic pathway in H1N1 IAV infection, we reported that FIX deficiency had no effect on survival after infection. 23 Interestingly, we observed that lack of FXII in mice increased the mortality after sub-lethal H1N1 IAV infection (Tatsumi et al, unpublished data). This discrepancy suggests that the intrinsic part of the blood coagulation was not needed to contribute to hemostasisdependent survival after H1N1 IAV infection. 23 of neutrophil adhesion and chemotaxis. 86 Unfortunately, the lack of in vivo studies makes it difficult to definitely conclude if the intrinsic pathway has any significant role in viral infections.
| HIV
HIV infection is associated increased TAT and D-dimer levels in plasma suggesting an ongoing activation of coagulation in HIV infection (Table 2) . [87] [88] [89] Further, the coagulation activation marker correlated with virus load and monocyte TF expression in HIV-infected patients. 90 Interestingly, TF expression seems to be restricted to CD14 + CD16 − CCR2 + monocytes. 91 Thrombin mediates the crosstalk between the coagulation system and the adaptive immune system at sites of vascular injury via PAR1 increasing T cell motility and proinflammatory cytokine production. 92 Importantly, HIV-infected antiretroviral therapy recipients exhibit, even with suppressed viremia, increased risk for cardiovascular disease due to ongoing thrombin-mediated signaling through PAR1 on CXCR1 + CD8 + T cells. 93 Thrombin further directly enhanced T cell receptor-mediated interferon (IFN) γ production by purified CD8 + T cells. However, the authors stressed that their analysis was limited due to the potential selective reporting bias in the analyzed studies. 96 Further large prospective studies should properly address if the new oral anticoagulants increase the risk for certain bacterial or viral infections.
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